Study finds unexpected bacterial diversity on human skinMay 29, 2009Genomic research lays groundwork for new approaches for treating, preventing skin diseases The health of our skin - one of the body's first lines of defense against illness and injury - depends upon the delicate balance between our own cells and the millions of bacteria and other one-celled microbes that live on its surface. To better understand this balance, National Institutes of Health researchers have set out to explore the skin's microbiome, which is all of the DNA, or genomes, of all of the microbes that inhabit human skin. Their initial analysis, published today in the journal Science, reveals that our skin is home to a much wider array of bacteria than previously thought. The study also shows that at least among healthy people, the greatest influence on bacterial diversity appears to be body location. For example, the bacteria that live under your arms likely are more similar to those under another person's arm than they are to the bacteria that live on your forearm. "Our work has laid an essential foundation for researchers who are working to develop new and better strategies for treating and preventing skin diseases," said Julia A. Segre, Ph.D., of the National Human Genome Research Institute (NHGRI), who was the study's senior author. "The data generated by our study are freely available to scientists around the world. We hope this will speed efforts to understand the complex genetic and environmental factors involved in eczema, psoriasis, acne, antibiotic-resistant infections and many other disorders affecting the skin." Drawing on the power of modern DNA sequencing technology and computational analysis, the research team from NHGRI, the National Cancer Institute (NCI) and the NIH Clinical Center uncovered a far more diverse collection of microbes on human skin than had been detected by traditional methods that involved growing microbial samples in the laboratory. The NIH study involved taking skin samples from 20 sites on the bodies of 10 healthy volunteers. "We selected skin sites predisposed to certain dermatological disorders in which microbes have long been thought to play a role in disease activity," said study coauthor Maria L. Turner, M.D., senior clinician in NCI's Dermatology Branch. The researchers extracted DNA from each sample and sequenced the 16S ribosomal RNA genes, which are a type of gene that is specific to bacteria. The researchers identified more than 112,000 bacterial gene sequences, which they then classified and compared. The analysis detected bacteria belonging to 19 different phyla and 205 different genera, with diversity at the species level being much greater than expected. To gauge how much the skin microbiome differs among healthy people, the researchers studied many different parameters. They found considerable variation in the number of bacteria species at different sites, with the most diversity being seen on the forearm (44 species on average) and the least diversity behind the ear (19 species on average). The research also generated information that may prove useful in efforts to combat the growing problem of methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that can cause serious, even life-threatening, infections. While it is known that a significant proportion of people have colonies of S. aureus inside their noses, the NIH team checked to see where else on the body surface that these bacteria thrive. They found that the crease of skin outside the nose is the site with the microbial community most similar to that found inside the nose. "Not only does our work shed new light on understanding an important aspect of skin biology, it provides yet another example of how genomic approaches can be applied to study important problems in biomedical research," said NHGRI's Scientific Director Eric D. Green, M.D., Ph.D., who is a co-author of the study. "This also demonstrates what can be achieved through efforts that pull together researchers from across NIH." NIH recently launched the Human Microbiome Project, a part of the NIH Roadmap for Medical Research, to discover what microbial communities exist in different parts of the human body and to explore how these communities change with disease. In addition to skin and nose, that project is sampling the digestive tract, the mouth and the vagina. The skin sites selected for the Science study represent three microenvironments: oily, moist and dry. The oily sites included between the eyebrows, beside the nose, inside the ear, back of the scalp, and upper chest and back. Moist areas were inside the nose, armpit, inner elbow, webbed area between the middle and ring fingers, side of the groin, top fold of the buttocks, behind the knee, bottom of the foot and the navel. Dry areas included the inside surface of the mid-forearm, the palm of the hand and the buttock. Researchers found that dry and moist skin had a broader variety of microbes than did oily skin. Oily skin contained the most uniform mix of microbes. To look for changes that may occur in the skin microbiome over time, the researchers sampled some volunteers twice, with the samples being taken about four to six months apart. Most of the re-sampled volunteers were more like themselves over time than they were like other volunteers. However, the stability of the microbial community was dependent on the site surveyed. The greatest stability was found in samples from inside the ear and nose, and the least stability was found in samples from behind the knee. "Our results underscore that skin is home to vibrant communities of microbial life, which may significantly influence our health," said the study's first author, Elizabeth Grice, Ph.D., who is a postdoctoral fellow at NHGRI. NIH/National Human Genome Research Institute |
|||||||||||||||||||||
| Related Bacterial Diversity Current Events and Bacterial Diversity News Articles Cigarettes Harbor Many Bacteria Harmful to Human Health Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France. What's Killing the Coral Reefs? The answer to what's killing the world's coral reefs may be found in a tiny chip that fits in the palm of your hand. Shifts in soil bacterial populations linked to wetland restoration success A new study led by Duke University researchers finds that restoring degraded wetlands -- especially those that had been converted into farm fields -- actually decreases their soil bacterial diversity. Microbes, by latitudes and altitudes, shed new light on life's diversity Microbial biologists, including the University of Oregon's Jessica L. Green, may not have Jimmy Buffett's music from 1977 in mind, but they are changing attitudes about evolutionary diversity on Earth, from oceanic latitudes to mountainous altitudes. Database shows effects of acid rain on microorganisms in Adirondack Lakes Prior to the federal Clean Air Act, unhindered industrial emissions were released into the air throughout the Midwestern and Eastern United States for decades. Many of those harmful chemicals came right back down to earth in the form of acid rain, a chemical concoction that includes nitric and sulfuric acid. Scientists Find Bacteria Thriving on a Feast of Seafloor Rock On the deep ocean floor, microbial life is feeding on fresh volcanic rock and flourishing with greater abundance than even the most optimistic scientists thought possible. According to a study published May 28 in the journal Nature, scientists have found bacteria growing on oceanic crust in concentrations that are thousands- to ten-thousand times (three to four orders of magnitude) greater than what is found in the overlying waters. Heavy metals in the Peak District -- evidence from bugs in blanket bogs Bacteria that consume heavy metals have been found in some of the most contaminated parts of the Peak District in the Southern Pennines and may be changing the pollutants into more toxic forms that could leak out into reservoirs. Ipsat Therapies Announces Positive Clinical Trial Results for the Prevention of Serious Infections Associated with Antibiotic Resistance Helsinki, October 13th 2003 - Ipsat Therapies, focused on developing products to prevent the spread of serious infections associated with antibiotic therapy and resistance, today presented positive Phase I clinical trial data for its lead product, P1A, at the BioPartnering Europe Conference in London. This product fulfils many of the criteria for fast track development by the FDA. Antibiotics have long been associated with infections, and bacterial resistance leading to the spread of infections. Commonly known resistant pathogens resulting in these serious infections are Methicillin Resistant Stapholococcus aureus, Clostridium difficile, Vancomycin Resistant Enterococci (VRE) and other gram More Bacterial Diversity Current Events and Bacterial Diversity News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||